BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1173538)

  • 1. Therapeutic effect of Leo 1031, an alkylating corticosteroid ester; in lymphoproliferative disorders. II. Lymphocytic lymphoma.
    Móller TR; Brandt L; Kónyves I; Lindberg G
    Acta Med Scand; 1975 Apr; 197(4):323-7. PubMed ID: 1173538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of Leo 1031, an alkylating corticosteroid ester, in lymphoproliferative disorders. I. chronic lymphocytic leukaemia.
    Brandt L; Kónyves I; Móller TR
    Acta Med Scand; 1975 Apr; 197(4):317-22. PubMed ID: 1136862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic lymphocytic leukemia and lymphosarcoma with a new chlorambucil ester of prednisolone (Leo 1031) (NSC-134087).
    Aungst CW; Mittelman A; Murphy GP
    J Surg Oncol; 1975; 7(6):457-60. PubMed ID: 1102806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednimustine (NSC-134087, Leo 1031) treatment of lymphocytic and lymphocytic-histiocytic lymphomas.
    Mattsson W; von Eyben F; Turesson I; Wählby S
    Cancer; 1978 Jan; 41(1):112-6. PubMed ID: 342081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia].
    Lutz D; Böhnel J
    Osterr Z Onkol; 1977; 3(5-6):155-9. PubMed ID: 323777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphosarcoma. A comparison of extended to conservative chemotherapy.
    Kaufman JH; Ezdinli E; Aungst CW; Stutzman L
    Cancer; 1976 Mar; 37(3):1283-92. PubMed ID: 946592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factors.
    Steward WP; Crowther D; McWilliam LJ; Jones JM; Deakin DP; Todd ID; Blackledge G; Wagstaff J; Scarffe JH; Harris M
    Cancer; 1988 Feb; 61(3):441-7. PubMed ID: 3338014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous treatment of non-Hodgkin's malignant lymphoma with prednimustine (Leo 1031).
    Håkansson L; Könyves I; Lindberg LG; Möller T
    Oncology; 1978; 35(3):103-6. PubMed ID: 673314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bendamustine, vincristine, prednisolone (BOP) in therapy of advanced low-grade non-Hodgkin lymphoma]].
    Kath R; Blumenstengel K; Fricke HJ; Peters HD; Höffken K
    Dtsch Med Wochenschr; 2001 Feb; 126(8):198-202. PubMed ID: 11256023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednimustine in mycosis fungoides: a report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hellbe L
    Acta Derm Venereol; 1979; 59(1):87-8. PubMed ID: 84481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of Leo 1031 (prednimustine) in advanced ovarian carcinoma.
    Johnsson JE; Tropé C; Mattsson W; Grundsell H; Aspegren K; Könyves I
    Cancer Treat Rep; 1979 Mar; 63(3):421-4. PubMed ID: 371798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose pulse chlorambucil: effective therapy for rapid remission induction in nodular lymphocytic poorly differentiated lymphoma.
    Cadman E; Drislane F; Waldron JA; Farber L; Prosnitz L; Bertino JR
    Cancer; 1982 Sep; 50(6):1037-41. PubMed ID: 7049345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.
    Lister TA; Cullen MH; Beard ME; Brearley RL; Whitehouse JM; Wrigley PF; Stansfeld AG; Sutcliffe SB; Malpas JS; Crowther D
    Br Med J; 1978 Mar; 1(6112):533-7. PubMed ID: 630211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
    Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
    Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
    Schein PS; Chabner BA; Canellos GP; Young RC; DeVita VT
    Cancer; 1975 Feb; 35(2):354-7. PubMed ID: 1089470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednimustine treatment in malignant lymphomas.
    Szántó I; Fleischmann T; Eckhardt S
    Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma.
    Portlock CS; Fischer DS; Cadman E; Lundberg WB; Levy A; Bobrow S; Bertino JR; Farber L
    Cancer Treat Rep; 1987 Nov; 71(11):1029-31. PubMed ID: 3677110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of chlorambucil in the treatment of bullous pemphigoid.
    Milligan A; Hutchinson PE
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):796-801. PubMed ID: 2189909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination versus successive single agent chemotherapy in lymphocytic lymphoma.
    Kennedy BJ; Bloomfield CD; Kiang DT; Vosika G; Peterson BA; Theologides A
    Cancer; 1978 Jan; 41(1):23-8. PubMed ID: 580070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of cytostatic polychemotherapy in non-Hodgkin lymphomas].
    Kratzer H; Hehenwarter W; Denz H; Bliem J; Tschurtschenthaler G; Nitsche D; Huber H; Michlmayr G
    Wien Klin Wochenschr; 1983 Aug; 95(16):558-62. PubMed ID: 6689099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.